AKT1 and cervical cancer: This was paralleled by enhanced NK cell cytotoxicity against human cervical cancer cells, achieved through the modulation of tumor cell surface expression of NK-cell activating ligands via the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway.